BINTAI - rises on partnership deal
Some news onward!
Bintai Kinden Corp Bhd’s shares rose marginally in early trade Friday after its partner signed an agreement to to develop and commercialise a coronavirus vaccine in China.
The counter added one sen to 72.5 sen with 20 million shares done. Bintai Kinden’s partner Generex Biotechnology Corporation has entered a framework agreement with Chinese agencies to develop and commercialise a coronavirus vaccine in China. Generex had entered the agreement with China Center for Disease Control and Prevention, Beijing Guoxin Haixiang Equity Investment Partnership and Beijing Youfeng International Consulting Co Ltd.
Notably watch
- price exceed expectation which more than 0.7
Bintai Kinden Corp Bhd’s shares rose marginally in early trade Friday after its partner signed an agreement to to develop and commercialise a coronavirus vaccine in China.
The counter added one sen to 72.5 sen with 20 million shares done. Bintai Kinden’s partner Generex Biotechnology Corporation has entered a framework agreement with Chinese agencies to develop and commercialise a coronavirus vaccine in China. Generex had entered the agreement with China Center for Disease Control and Prevention, Beijing Guoxin Haixiang Equity Investment Partnership and Beijing Youfeng International Consulting Co Ltd.
Notably watch
- price exceed expectation which more than 0.7
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.